(19)
(11) EP 2 540 723 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
28.01.2015 Bulletin 2015/05

(45) Mention of the grant of the patent:
26.11.2014 Bulletin 2014/48

(21) Application number: 12178110.8

(22) Date of filing: 20.06.2008
(51) International Patent Classification (IPC): 
C07D 471/10(2006.01)
A61P 3/04(2006.01)
 A61K 31/444(2006.01)

(54)

Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1

Spirocyclen als Hemmer der 11beta-Hydroxysteroid-Dehydrogenase vom Typ 1

Spirocycles utilisés comme inhibiteurs de la 11-beta-hydroxystéroïde déshydrogénase de type 1

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA MK RS

(30) Priority: 21.06.2007 US 945487 P

(43) Date of publication of application:
02.01.2013 Bulletin 2013/01

(60) Divisional application:
14193608.8

(62) Application number of the earlier application in accordance with Art. 76 EPC:
08771573.6 / 2173750

(73) Proprietor: Incyte Corporation
Wilmington, DE 19803 (US)

(72) Inventors:
  • Yao, Wenqing
    Chadds Ford, PA 19317 (US)
  • Zhuo, Jincong
    Boothwyn, PA Pennsylvania 19061 (US)
  • Zhang, Colin
    Ambler, PA Pennsylvania 19002 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)


(56) References cited: : 
WO-A1-2006/053204
 WO-A2-2007/067504
   
     
    Remarks:
    The file contains technical information submitted after the application was filed and not included in this specification
     
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).